Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc-Max response elements.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cancer Research

• Publication date

  1996-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8542591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system.

  1994cited by this paper
• A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung.

  1994cited by this paper
• Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene.

  1994cited by this paper
• Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA.

  1993cited by this paper
• Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.

  1993cited by this paper
• The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

  1993cited by this paper
• Topics in clinical pharmacology: ganciclovir.

  1992cited by this paper
• Myc and Max proteins possess distinct transcriptional activities

  1992cited by this paper
• In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

  1992cited by this paper
• Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells

  1992cited by this paper
• Interactions of lung cancer cells with the human mesothelial cell monolayer: an in vitro model for cancer invasion.

  1992cited by this paper
• Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

  1991cited by this paper
• Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region.

  1991cited by this paper
• Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy.

  1991cited by this paper
• Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer.

  1990cited by this paper
• Sequence-specific DNA binding by the c-Myc protein.

  1990cited by this paper
• Chemo‐radioresistance of Small Cell Lung Cancer Cell Lines Derived from Untreated Primary Tumors Obtained by Diagnostic Bronchofiberscopy

  1990cited by this paper
• Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.

  1989cited by this paper
• Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.

  1986cited by this paper
• Promoter domains required for expression of plasmid-borne copies of the herpes simplex virus thymidine kinase gene in virus-infected mouse fibroblasts and microinjected frog oocytes

  1985cited by this paper
• Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

  1982cited by this paper
• Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1.

  1981cited by this paper
• Clinical biology of small cell carcinoma: relationship to surgical therapy.

  1978cited by this paper

• Advances in Cancer Gene Therapy [MJM 1996 2: 93-106]

  2020cites this paper
• Recombinant adenovirus of SEA and CD80 genes driven by MMRE and mouse TERT promoter induce effective antitumor immune responses against different types of tumor cells in vitro and in vivo.

  2017cites this paper
• Calretinin mediates apoptosis in small cell lung cancer cells expressing tetraspanin CD9☆

  2013cites this paper
• C-Myc et lymphomagenèse dans les cellules B infectées par le virus d’Epstein-Barr

  2009cites this paper
• Improved low molecular weight Myc-Max inhibitors

  2007cites this paper
• Evaluation of Molecular Inhibitors of the c-Myc Oncoprotein

  2007cites this paper
• The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer

  2006cites this paper
• The Extracellular Domain of p185c-neu Induces Density-Dependent Inhibition of Cell Growth in Malignant Mesothelioma Cells and Reduces Growth of Mesothelioma In Vivo

  2006cites this paper
• Delivery of Viral Vectors to Tumor Cells: Extracellular Transport, Systemic Distribution, and Strategies for Improvement

  2006cites this paper
• Gene therapy for lung cancer

  2006cites this paper
• Replacement and suicide gene therapy for targeted treatment of lung cancer.

  2005cites this paper
• Enhanced Expression of Apoptin by the Myc–Max Binding Motif and SV40 Enhancer for SCLC Gene Therapy

  2005cites this paper
• Adenovirus-Mediated Suicide SCLC Gene Therapy Using the Increased Activity of the hTERT Promoter by the MMRE and SV40 Enhancer

  2005cites this paper
• Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery

  2005cites this paper
• c-Myc as a therapeutic target in cancer

  2004cites this paper
• Endocrine aspects of cancer gene therapy.

  2004cites this paper
• Transcriptional Targeting in Cancer Gene Therapy

  2003cites this paper
• Current status of gene therapy for lung cancer and head and neck cancer.

  2003cites this paper
• The MYC oncogene as a cancer drug target.

  2003influential citation
• Electroporation-mediated and EBV LMP1-regulated gene therapy in a syngenic mouse tumor model

  2003cites this paper
• Evaluation of combined gene regulatory elements for transcriptional targeting of suicide gene expression to malignant melanoma

  2003cites this paper
• Recent advances in the molecular biology, diagnosis and novel therapies for various small blue cell tumors.

  2003cites this paper
• Clinical and Molecular Features of Small cell Lung Cancer

  2002cites this paper
• Adenovirus‐mediated gene therapy specific for small cell lung cancer cells using a Myc‐Max binding motif

  2001cites this paper
• Suicide gene therapy for pediatric tumors

  2001cites this paper
• Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression.

  2001cites this paper
• Expression Achieve Efficient c-MYC-or N-MYC-regulated Protein Use of a Modified Ornithine Decarboxylase Promoter to Updated Version

  2001cites this paper
• Novel molecular and immunotherapeutic strategies for lung cancer.

  2001cites this paper
• Transcriptional regulation in cancer gene therapy.

  2001cites this paper
• Gene therapy utilizing the Cre/loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen‐producing cancer cells

  2001cites this paper
• Conditional gene targeting for cancer gene therapy.

  2001cites this paper
• Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma.

  2001cites this paper
• Apoptosis in cancer: therapeutic implications.

  2000cites this paper
• Gene therapy for lung cancer.

  2000cites this paper
• Gene regulation of vasopressin and vasopressin receptors in cancer

  2000cites this paper
• Use of gastrin‐releasing peptide promoter for specific expression of thymidine kinase gene in small‐cell lung carcinoma cells

  2000cites this paper
• Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11.

  2000cites this paper
• Molecular Chemotherapy for Breast Cancer

  1999cites this paper
• Amplification of the C-MYC Oncogene in Non-small Cell Lung Cancer

  1999cites this paper
• New perspectives for the pharmacological and biological therapy of small cell lung cancer.

  1999cites this paper
• Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy.

  1999cites this paper
• Therapy against Carcinoembryonic Antigen-producing Cancer Enhances Antitumor Effects in Cell Type-specific Gene System Further loxP Application of the Cre Recombinase / Updated

  1999cites this paper
• Gene therapy for lung cancer.

  1999cites this paper
• Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer

  1999cites this paper
• Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.

  1999cites this paper
• Effects of polyamines, polyamine synthesis inhibitors, and polyamine analogs on casein kinase II using Myc oncoprotein as substrate.

  1999cites this paper
• Gene Therapy for Cancer: Prospects for the Treatment of Lung Tumours

  1999cites this paper
• Gene-directed enzyme prodrug therapy.

  1998cites this paper
• Transcriptional activation of NF-κB activity by Epstein–Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases

  1998cites this paper
• Molecular Aspects of Cancer and its Therapy

  1998influential citation
• RADIOSENSITIVITY AND CANCER-RELATED GENES

  1997cites this paper
• Targeting gene therapy to cancer: a review.

  1997cites this paper
• Gene therapy of cancer

  1996cites this paper